Agios MDS and Organ Impairment study

Clinical Trial Grant

Duke Scholars

Principal Investigator Harry Paul Erba Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Agios Pharmaceuticals, Inc.

Start Date

July 16, 2020

End Date

August 14, 2025

Administered By

Duke Cancer Institute

Awarded By

Agios Pharmaceuticals, Inc.

Start Date

July 16, 2020

End Date

August 14, 2025